P
PharmaCann
Biotech & Life Sciences · Oak Park, United States · Founded 2014
largest vertically-integrated and unified medical cannabis company MoreLess
PharmaCann is a prominent player in the cannabis industry, dedicated to improving people's lives through the cultivation, production, and distribution of high-quality cannabis products. Founded in 2014, PharmaCann has quickly grown to become one of the largest vertically integrated cannabis companies in the United States. This means they control every step of the process—from growing the cannabis plants to processing them into various products and finally selling them in their own dispensaries. This vertical integration allows PharmaCann to maintain high standards of quality and safety across all their products.
The company operates in a rapidly expanding market, focusing on both medical and adult-use cannabis. They are licensed to operate in eight states, including Illinois, Maryland, Massachusetts, New York, Ohio, and Pennsylvania. Their product offerings include a range of cannabis-related items such as flower, edibles, tinctures, and topicals, all designed to meet the diverse needs of their clients.
PharmaCann serves a broad spectrum of clients, from medical patients seeking relief from various conditions to adult consumers looking for wellness and recreational products. The company’s mission is to provide safe, reliable, and top-quality cannabis products that are both effective and affordable. By investing in their employees, state-of-the-art facilities, and rigorous research and development, PharmaCann aims to lead the industry in innovation and quality.
The business model of PharmaCann revolves around vertical integration, which helps them control costs and ensure product quality. They make money by selling their products directly to consumers through their network of dispensaries, as well as through wholesale channels to other retailers. Their commitment to truth and transparency, along with their focus on sustainable practices, positions them as a trusted name in the cannabis industry.
Keywords: Cannabis, Vertically Integrated, Dispensaries, Medical, Adult-Use, Quality, Affordable, Reliable, Wellness, Innovation.
Company overview
PharmaCann company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Oak Park, United States
- Employees
- 671
- Open positions
- 41
- Dealroom signal
- 74.2
Valuation & funding
PharmaCann funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Apr 2024 | $74M | — | Undisclosed | ↗ |
| GROWTH EQUITY VCOther financing | Apr 2024 | $18M | — | Undisclosed | ↗ |
| DEBTDebt | Apr 2023 | $9M | — | Undisclosed | ↗ |
| DEBTDebt | Jan 2022 | $40M | — | Undisclosed | ↗ |
| ACQUISITIONOther financing | Oct 2018 | $682M | — | MedMen | ↗ |
| LATE VCOther financing | Jun 2018 | Undisclosed | — | ||
| DEBTDebt | Jan 2017 | Undisclosed | — | ||
| EARLY VCOther financing | Oct 2014 | Undisclosed | — |
Growth signals
PharmaCann website traffic
Latest recorded traffic for PharmaCann is 11K monthly website visits, up 17% over the last three months. PharmaCann's team grew 38.1% over the past year.
Hiring
Open positions at PharmaCann
Current openings linked to this company in Dealroom.
Comparisons
PharmaCann compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
PharmaCann's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on PharmaCann's cap table
Sourced from Dealroom's funding and investor records.

Global footprint
Where PharmaCann has talent and traffic
team presence
In the news
Latest news about PharmaCann
Recent press, funding announcements, and product moves mentioning PharmaCann — open to read from the original sources.
Market sentiment
What the market is saying about PharmaCann
An AI-synthesized read of the highest-engagement posts about PharmaCann on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PharmaCann’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







